Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GlaxoSmithKline PLC Director's Dealing 2015

Oct 19, 2015

5262_dirs_2015-10-19_4527c5ec-21e3-4578-aaf6-1bde1e9379da.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 7108C

GlaxoSmithKline PLC

19 October 2015

GlaxoSmithKline plc

Notification of Transactions of Directors, Persons Discharging Managerial Responsibilities or Connected Persons

In accordance with DTR 3.1.4 R(1)(c) I give details of changes in the interests of Sir Andrew Witty, an Executive Director, in the Ordinary Shares of GlaxoSmithKline plc ('GSK'). GSK was advised on 19 October 2015 that Sir Andrew Witty's Connected Person acquired 5 GSK Ordinary Shares on 13 October 2015 at a price of 1319.64 pence per Share, following the re-investment of dividends on Shares held within an ISA. The dividend was paid to shareholders on 1 October 2015.

V A Whyte

Company Secretary

19 October 2015

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSXKLFFEBFXFBF